See the DrugPatentWatch profile for akynzeo
Akynzeo is a medication used to prevent nausea and vomiting associated with chemotherapy [1]. It is a combination drug containing netupitant and palonosetron [1]. Netupitant is a neurokinin-1 (NK-1) receptor antagonist, and palonosetron is a selective serotonin 5-HT3 receptor antagonist [1].
How Does Akynzeo Work to Prevent Nausea and Vomiting?
Akynzeo works by blocking two key pathways that trigger chemotherapy-induced nausea and vomiting (CINV). Netupitant targets the NK-1 receptor, which is involved in the delayed phase of CINV, while palonosetron targets the 5-HT3 receptor, a primary pathway for acute CINV [1]. By acting on both receptors, Akynzeo provides comprehensive protection against both the immediate and later-onset symptoms of nausea and vomiting [1].
What Are the Common Side Effects of Akynzeo?
Patients taking Akynzeo may experience side effects such as headache, fatigue, and constipation [1]. Less common side effects can include hiccups, indigestion, and decreased appetite [1].
How Is Akynzeo Administered?
Akynzeo is typically administered intravenously or orally [1]. The specific method and timing of administration depend on the chemotherapy regimen being used [1].
How Long Does Akynzeo's Protection Last?
Akynzeo is designed to provide protection against nausea and vomiting for an extended period following chemotherapy administration [1]. Its dual mechanism helps manage both acute and delayed symptoms.
Are There Alternatives to Akynzeo for Chemotherapy-Induced Nausea and Vomiting?
Several other medications are available to manage CINV, including other NK-1 receptor antagonists and 5-HT3 receptor antagonists, as well as corticosteroids [2]. The choice of antiemetic therapy often depends on the patient's specific chemotherapy regimen and individual risk factors for CINV [2].
What Is the Role of Drug Patents in Medications Like Akynzeo?
Drug patents protect the intellectual property of pharmaceutical companies, granting them exclusive rights to market a drug for a specific period [3]. This exclusivity allows companies to recoup their research and development costs. Patents for drugs like Akynzeo, which combine multiple active ingredients or have novel formulations, can be complex [3]. Information on patent expiry dates and potential challenges can be found on resources like DrugPatentWatch.com [3].
When Does the Patent for Akynzeo Expire?
Specific patent expiry dates for Akynzeo would need to be consulted through patent databases or specialized services such as DrugPatentWatch.com [3].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/